Home
Reels
Gruplar
Sayfalar
Daha fazla gör
Gruplar Sayfalar Events Blogs Offers Jobs Courses Forums Movies Merits
Giriş yapın Başvur
Theme Switcher
Night Mode
FDA/EMA Fast-Track Approvals Accelerate Lung Cancer Drug Launches: 15 New Therapies Expected by 2028, Market Report Reveals
Regulatory agencies like the FDA and EMA are accelerating approvals for lung cancer therapies, driven by urgent unmet needs and advancements in real-world evidence (RWE). These policy shifts are reshaping the market, reducing time-to-market for new drugs and encouraging innovation in underserved subtypes. The Lung Cancer Therapeutics Market, valued at $35 billion in 2023, is set to welcome 15...
0 Yorumlar ·0 hisse senetleri ·113 Views ·0 önizleme
Please log in to like, share and comment!